Barcelona to be Spain HQ for Sanofi-Aventis

24 October 2004

Newly-merged drugs group Sanofi-Aventis is to establish its Spanish headquarters in Barcelona and centralize distribution in Madrid, the company's communications director, Gloria Pujol, has told the Marketletter. Ms Pujol confirmed that both Madrid and Barcelona had competed for the spot but that group executives decided the slightly bigger Catalan office was better suited for the role.

"Sanofi-Synthelabo has been in Barcelona for over 20 years and has more visibility here than in Madrid," she said, adding that it is the only other large foreign multinational in the Catalonia region, apart from Novartis. The Catalan government's support for the initiative also convinced Sanofi-Aventis to settle its Spanish executive board in Barcelona. The board will be led by Aventis director general Belen Garijo; Sanofi chief Jacques Cessot is to take a "major" management post at the group in France.

Now 2nd-largest drugmaker in Spain

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight